Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Osteoporosis and Multiple Sclerosis: Risk Factors, Pathophysiology, and Therapeutic Interventions.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
An analytical model for estimating water exchange rate in white matter using diffusion MRI.
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.
Cell-based therapy approaches: the hope for incurable diseases.
Minocycline attenuates experimental autoimmune encephalomyelitis in rats by reducing T cell infiltration into the spinal cord.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Longitudinal interferon-β effects in multiple sclerosis: Differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.
Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis.
Assisted reproduction technology in multiple sclerosis: Giving birth to a new avenue of research in hormones and autoimmunity.
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Prevalence and Significant Determinants of Post-traumatic Stress Disorder in a Large Sample of Patients with Multiple Sclerosis.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Arterial, venous and other vascular risk factors in multiple sclerosis.
Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis.
Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
A case of multiple sclerosis with pure, massive superficial demyelination.
Neuroplasticity and functional recovery in multiple sclerosis.
Pages
« first
‹ previous
…
213
214
215
216
217
218
219
220
221
…
next ›
last »